Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
Nippon India Nifty Pharma ETF
[Equity: Index]  
 
Fund Details
Fund Type Growth Launch Date 02-Jul-21
Corpus(Cr.) 1736.00 Latest NAV 27.4607 As on 29-10-2026
Equity(%) 99.94 52 Week High 27.9587
Debt(%) 0.06 52 Week Low 22.0529
Others(%) 0.00 Exit Load 0
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark NIFTY Pharma TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Jitendra Tolani
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 54.59%
Top 10 Holdings 78.16%
Top 25 Holdings 100.00%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 99.94
Cash 0.06
 
 
 
 
 
Portfolio Metrics
PB Ratio 4.90
PE Ratio 39.49
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Ltd. 19.50
Divis Laboratories Ltd. 11.97
Laurus Labs Limited 7.82
Cipla Ltd. 7.68
Dr. Reddys Laboratories Ltd. 7.62
Torrent Pharmaceuticals Ltd. 7.16
Lupin Ltd 5.00
Aurobindo Pharma Ltd. 4.69
Glenmark Pharmaceuticals ltd 3.56
Alkem Laboratories Limited 3.16
Zydus Lifesciences Limited 2.92
Mankind Pharma Limited 2.88
Ipca Laboratories Ltd. 2.71
Biocon Ltd. 2.62
Gland Pharma Limited 2.34
Sai Life Sciences Limited 2.14
Wockhardt Ltd 1.77
Ajanta Pharma Ltd. 1.67
Abbott India Ltd. 1.43
PIRAMAL PHARMA LIMITED 1.30
Triparty Repo 0.18
Net Current Assets -0.12

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-0.84% 1.27% 15.09% 19.51%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [NSE - Nifty Pharma]
-0.83% 1.28% 14.83% 19.08%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
9.18% 22.35% 14.55% 0.00%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
8.71% 21.85% 13.98% 8.72%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Nippon India Nifty Pharma ETF 16.19% 0.8330 11.9311% 45.5645 0.1209
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Nippon India Nifty Pharma ETF 14.4179% 0.0000 -8.3191 21.0941 1.6142
 
Back to Selection